Practitioners who work with AOD-9604 do so under research-use frameworks, and the evidence base for efficacy, while mechanistically interesting, did not survive the Phase IIb primary endpoint test
Studies confirm 50% drops by midlife, linking to aging symptoms.[1][9] Restoring NAD+ has been shown in animal studies to improve lifespan and healthspan, with human trials indicating benefits in muscle function and cognitive performance
Your dosage depends on several things
Researchers generally favor AOD-9604 because it selectively stimulates lipolysis while minimally impacting blood glucose or growth pathways
The MHRA may consider the active substance, intended purpose, pharmacological action, claims, imagery and wider product presentation